Globus Medical (GMED) EBITDA Margin (2011 - 2026)
Globus Medical (GMED) posted EBITDA Margin of 19.79% for Q1 2026, down 3.41% on a QoQ basis from 20.49% in Q4 2025, and up 357.0% year-over-year from 4.33% in Q1 2025.
Globus Medical (GMED) EBITDA Margin (2011 - 2026) Analysis & Trends
Globus Medical's EBITDA Margin history runs 16 years deep, the most recent figure standing at 19.79% for Q1 2026.
- Quarterly EBITDA Margin rose 357.0% year-over-year to 19.79% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17.2% (up 704.0% YoY) and the FY2025 annual result came in at 16.33%, up 974.0% from the prior year.
- EBITDA Margin was 19.79% for Q1 2026 at Globus Medical, down from 20.49% in the prior quarter.
- Across five years, EBITDA Margin topped out at 25.71% in Q2 2022 and bottomed at 0.11% in Q3 2023.
- A 5-year average of 14.38% and a median of 17.86% in 2025 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2023 — EBITDA Margin plunged 2339 bps — and 2025, when it jumped 1490 bps.
- Globus Medical's EBITDA Margin stood at 19.68% in 2022, then sank by 92 bps to 1.64% in 2023, then jumped by 458 bps to 9.17% in 2024, then soared by 123 bps to 20.49% in 2025, then dropped by 3 bps to 19.79% in 2026.
- Business Quant data shows GMED's EBITDA Margin at 19.79% in Q1 2026, 20.49% in Q4 2025, and 17.86% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Globus Medical | 10.21 Bn | 9.58 Bn | 525.79 Mn | 19.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.79% |
| Dec 31, 2025 | 20.49% |
| Sep 30, 2025 | 17.86% |
| Jun 30, 2025 | 10.21% |
| Mar 31, 2025 | 16.22% |
| Dec 31, 2024 | 9.17% |
| Sep 30, 2024 | 7.69% |
| Jun 30, 2024 | 7.88% |
| Mar 31, 2024 | 1.32% |
| Dec 31, 2023 | 1.64% |
| Sep 30, 2023 | 0.11% |
| Jun 30, 2023 | 22.71% |
| Mar 31, 2023 | 20.39% |
| Dec 31, 2022 | 19.68% |
| Sep 30, 2022 | 23.49% |
| Jun 30, 2022 | 25.71% |
| Mar 31, 2022 | 20.15% |
| Dec 31, 2021 | 7.28% |
| Sep 30, 2021 | 23.21% |
| Jun 30, 2021 | 18.28% |